For example, EGCG has been shown to exert anti-obesity effects through AMPK activation, which triggers the downregulation of SREBP transcription factors and upregulates the expression of two lipogenic enzymes: HMGCR and FASN [45]. The gene discussed is FASN; the disease is Obesity.